Please login to the form below

Not currently logged in
Email:
Password:

Jakafi

This page shows the latest Jakafi news and features for those working in and with pharma, biotech and healthcare.

Incyte launches award programme recognising innovation in GVHD community

Incyte launches award programme recognising innovation in GVHD community

That includes Incyte, which has a JAK 1/2 inhibitor – Jakafi – on the market as a treatment for acute GVHD, for adults and children 12 years of age and older whose

Latest news

More from news
Approximately 5 fully matching, plus 16 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics